Journal of Clinical Psychopharmacology

SJR Rank #11,393H-index: 137SJR: 0.523Best quartile: Q3
Journal website: aims, scope and author guidelines
Publisher

Lippincott Williams and Wilkins

Country

United States

Type

journal

SJR by Edition

2022202500.20.40.60.8

Subject Categories

  • Pharmacology (medical)Q3
  • Psychiatry and Mental HealthQ3

Areas: Medicine

Most published research topics

Schizophrenia research and treatmentTreatment of Major DepressionElectroconvulsive Therapy StudiesBipolar Disorder and TreatmentEpilepsy research and treatmentPharmacological Effects and Toxicity StudiesAnxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesNeurotransmitter Receptor Influence on BehaviorAttention Deficit Hyperactivity DisorderTryptophan and brain disorders

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs0150300450600

Documents per Year

2022202504590135180

Detailed Information

ISSN

1533-712X, 0271-0749

SJR Best Quartile

Q3

Region

Northern America

Citations per Document (2 years)

1.40

References per Document

28.83

Coverage

1981-2026

Scope

Journal of Clinical Psychopharmacology, a leading publication in psychopharmacology, offers a wide range of articles reporting on clinical trials and studies, side effects, drug interactions, overdose management, pharmacogenetics, pharmacokinetics, and psychiatric effects of non-psychiatric drugs. The journal keeps clinician-scientists and trainees up-to-date on the latest clinical developments in psychopharmacologic agents, presenting the extensive coverage needed to keep up with every development in this fast-growing field.

Metrics from SCImago Journal Rank 2025. View on SCImago